Help ?

IGMIN: あなたがここにいてくれて嬉しいです. お願いクリック '新しいクエリを作成してください' 当ウェブサイトへの初めてのご訪問で、さらに情報が必要な場合は.

すでに私たちのネットワークのメンバーで、すでに提出した質問に関する進展を追跡する必要がある場合は, クリック '私のクエリに連れて行ってください.'

Subjects Content

Welcome to IgMin Research – an Open Access journal uniting Biology Group, Medicine Group, and Engineering Group. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Biology Group

The Biology Group explores diverse topics in life sciences, providing open access to cutting-edge research and fostering global collaboration in biological studies.

Medicine Group

The Medicine Group focuses on advancing medical knowledge through open access research, promoting innovation, and encouraging global collaboration in healthcare studies.

Engineering Group

The Engineering Group showcases cutting-edge research across engineering fields, providing open access and encouraging global collaboration and innovation.

General Science Group

The General Science Group covers a broad range of scientific disciplines, offering open access to research that drives innovation and fosters global collaboration.

Members Content

We focus on accelerating knowledge through shared interdisciplinary collaboration.

Articles Content

We focus on accelerating knowledge through shared interdisciplinary collaboration.

Identify Us

We focus on accelerating knowledge through shared interdisciplinary collaboration.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
publications.support@igmin.org
E-Books Support
ebooks.support@igmin.org
Webinars & Conferences Support
webinarsandconference@igmin.org
Content Writing Support
contentwriting.support@igmin.org

Search

Explore Section

Content for the explore section slider goes here.

Medicine

Hematology at IgMin Research | Medicine Group

We focus on accelerating knowledge through shared interdisciplinary collaboration.

について

Hematology is the branch of medicine dedicated to the study, diagnosis, and treatment of blood-related disorders. This field encompasses a wide range of conditions, including anemia, clotting disorders, leukemias, lymphomas, and hemophilia. Hematologists work to understand the intricate dynamics of blood cells, bone marrow, and the coagulation system, providing life-saving care through innovative therapies and transfusion medicine.

As a rapidly advancing discipline, hematology has been transformed by breakthroughs in molecular biology, immunotherapy, and gene editing technologies. From improving outcomes in blood cancers to managing chronic hematologic diseases, hematology plays a pivotal role in modern medicine. Its integration with oncology, immunology, and genetics highlights its importance in addressing complex health challenges.

  • Anemia management
  • Blood clotting disorders
  • Leukemia research and treatment
  • Lymphoma management
  • Hemophilia and bleeding disorders
  • Bone marrow transplantation
  • Myelodysplastic syndromes
  • Hematologic malignancies
  • Sickle cell disease
  • Thalassemia care
  • Coagulation pathway research
  • Advances in transfusion medicine
  • Pediatric hematology
  • Hematologic diagnostics
  • Platelet disorders
  • Iron metabolism disorders
  • Blood cancers and immunotherapy
  • Hematopoietic stem cell therapy
  • Genetic blood disorders
  • Red blood cell disorders
  • White blood cell abnormalities
  • Thrombosis and embolism management
  • Advances in anticoagulant therapy
  • Blood typing and cross-matching
  • Hematology and immunology
  • Chronic lymphocytic leukemia
  • Role of AI in hematology
  • Hematology in pregnancy
  • Plasma cell disorders
  • Multiple myeloma treatment
  • Hematology and infections
  • Autoimmune blood disorders
  • Advances in hemostasis
  • Erythropoiesis-stimulating agents
  • Biomarkers in hematology
  • Precision medicine in blood disorders
  • Hemoglobinopathies
  • Innovations in hematologic imaging
  • Nutritional aspects in hematology
  • Stem cell donor registries
  • Advances in platelet transfusion
  • Geriatric hematology
  • Hematologic complications in chronic diseases
  • Bone marrow failure syndromes
  • Advances in blood storage
  • Acute myeloid leukemia treatment
  • Hematology in critical care
  • Pediatric leukemia advancements
  • Emerging therapies in hematology.

Medicine Group (2)

Short Communication Article ID: igmin262
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

Quality Culture - Lessons Learned from the Low- and Medium Income World
by Cees Th Smit Sibinga

With the development of safe blood supply and transfusion comes the introduction of quality as a culture, implemented through the introduction of a Quality System (QS) and Quality Management System (QMS). Often the idea is that– ‘when instructions are written (SOPs) a quality system is in place. Just follow the instructions, that is it.’ However, quality only partly depends on following instructions at the operational level. Generally not understood is the importance of designing and implementing a quality management system, b...ased on 5 key elements 1) organization and structure; 2) standards (technical and quality); 3) documentation - traceability and evidence; 4) education - continued teaching and training; 5) assessment - continued monitoring and evaluation.Development and implementation of an appropriate quality system and management were evaluated for 15 developing countries (2004-2020) in 4 WHO regions. Projects were based on a step-by-step introduction to the concept and principles of quality following a Quality Management Training (QMT) course – modular, interactive, with improvement score evaluation focused on comprehension and ownership of the teaching and training contents.For an optimal understanding of the values of quality in Transfusion Medicine (TM), a culture has to be created - ownership development, commitment to and implementation of the principles of fitness for purpose, and the supplier-producer-customer continuum.

Haematology Public Health
Mini Review Article ID: igmin234
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

Mastocytosis: Principles and Pitfalls in the Diagnosis of a Unique Disease
by Martina Rudelius*

Mastocytosis, a hematological neoplasm, manifests with diverse clinical, molecular, and histomorphological features. This review explores the different subtypes of mastocytosis, focusing on the role of molecular pathology and histomorphology in diagnosing systemic mastocytosis (SM). Systemic mastocytosis is characterized by histologically confirmed extracutaneous involvement, presenting a diagnostic challenge due to its rarity and diverse subtypes, ranging from occult SM to mast cell leukemia. The complexity of accurate SM diagnosis underscores... the necessity for a comprehensive understanding of the disease spectrum. Mastocytosis emerges as a rare, multifaceted disease, predominantly affecting children in the cutaneous form and adults in the systemic variant. The review advocates a multidisciplinary diagnostic approach involving experienced hematopathologists and haematooncologists, employing conventional histomorphology, immunohistochemistry, and molecular techniques. This holistic approach is crucial for accurate diagnosis, especially in light of recent therapeutic advances, particularly the growing importance of tyrosine kinase inhibitors (TKI) in the management of mastocytosis.

Haematology PathologyInternal Medicine
Hematology
研究を公開する

私たちは、科学、技術、工学、医学に関する幅広い種類の記事を編集上の偏見なく公開しています。

提出する

見る 原稿のガイドライン 追加 論文処理料

IgMin 科目を探索する
グーグルスカラー
welcome Image

Google Scholarは2004年11月にベータ版が発表され、幅広い学術領域を航海する学術ナビゲーターとして機能します。それは査読付きジャーナル、書籍、会議論文、論文、博士論文、プレプリント、要約、技術報告書、裁判所の意見、特許をカバーしています。 IgMin の記事を検索